JACOBS LEVY EQUITY MANAGEMENT, INC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,342,000
+54.4%
1,677,146
+129.6%
0.01%
+50.0%
Q3 2021$869,000730,3880.01%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$9,489,00030.38%
Consonance Capital Management LP 1,563,003$1,860,0001.02%
Wellington Shields & Co., LLC 1,832,769$2,181,0000.76%
Wellington Shields Capital Management, LLC 2,258,265$2,687,0000.37%
Ghost Tree Capital, LLC 650,000$774,0000.23%
Ikarian Capital, LLC 1,223,067$1,456,0000.10%
1492 Capital Management LLC 78,762$94,0000.05%
Sterneck Capital Management, LLC 40,000$48,0000.03%
FEDERATED HERMES, INC. 10,150,000$12,079,0000.02%
XTX Topco Ltd 41,324$49,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders